Green Q Liquid (Domperidone)

Adult dose

Adults: Administer 10mg of domperidone (5mg when administered with levodopa) orally 3 times daily before meals. The maximum daily dose is 30mg. In general, do not use for more than 1 week.

Child dose

Adolescents (12 years and older, weighing 35kg or more): Administer 10mg of domperidone (5mg when administered with levodopa) orally 3 times daily before meals. The maximum daily dose is 30mg.

This medication should not be used in certain patients. For example, it can be dangerous for patients with allergies to its ingredients, gastrointestinal bleeding, mechanical obstruction, or perforation. Additionally, patients with prolactin-secreting tumors or those taking certain strong CYP3A4 inhibitors or medications that prolong the QTc interval should not take this medicine. It is also advisable not to use this medication in patients with moderate to severe liver impairment, or in pregnant women or women who may become pregnant. Administration is prohibited for patients with prolonged cardiac conduction intervals, electrolyte imbalances, heart disease such as heart failure, etc. This medication contains lactose and should be avoided by patients with lactose intolerance or related genetic disorders. Care should be taken when administering this drug to children, patients with renal impairment or mild liver impairment, elderly patients, and those with heart disease. Especially for elderly patients, dosage adjustment or cautious administration is necessary due to decreased bodily functions. Side effects such as dry mouth, drowsiness, headache, diarrhea, rash, itching, and excessive milk secretion may occur when taking this medication, and in rare cases, serious cardiac arrhythmias or allergic reactions have been reported. Therefore, any abnormal symptoms should be promptly discussed with a physician. This medication is primarily metabolized in the liver, so caution is needed in patients with liver damage, and those with severely impaired renal function may require dosage adjustment. Patients with a history of breast cancer should use this medicine cautiously as it may affect prolactin secretion. Drowsiness or dizziness may occur after taking this drug, so it is best to avoid activities requiring concentration, such as driving or operating machinery. This medication may interact with various drugs, so patients taking other medications must consult their doctor or pharmacist, especially when used concurrently with drugs that affect the heart. It is recommended that pregnant or breastfeeding women do not use this medication, and if breastfeeding, they should consult with experts as adverse effects may occur in the infant. Pediatric dosing is limited according to weight, and caution is necessary, especially for infants under 1 year old, as neurological adverse reactions may occur. In cases of overdose, symptoms such as agitation, dizziness, convulsions, and confusion may appear, and there is no specific antidote, so affected individuals should visit a medical facility immediately for appropriate treatment. This medication must be kept out of the reach of children and stored in its original container to prevent misuse or deterioration of quality.

Dyspepsia

Drug interactions

This medication may interact with strong CYP3A4 inhibitors. Such inhibitors include fluconazole, itraconazole, ketoconazole, voriconazole, clarithromycin, erythromycin, telithromycin, amprenavir, atazanavir, fosamprenavir, indinavir, nelfinavir, ritonavir, and saquinavir. It may also interact with medications that prolong cardiac conduction intervals such as QTc.

This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is important to store it at room temperature, maintaining an environment that is neither too hot nor too cold.

Appearance

Light brown liquid

Package unit

75mL/bottle